Development and Application of Kinetic Spectrophotometric Method for the Determination of Metronidazole
Purpose: To develop an improved kinetic-spectrophotometric procedure for the determination of metronidazole (MNZ) in pharmaceutical formulations.
Methods: The method is based on oxidation reaction of MNZ by hydrogen peroxide in the presence of Fe(II) ions at pH 4.5 (acetate buffer). The reaction was monitored spectrophotometrically by measuring the rate of change of absorbance at 317nm.
Results: The optimum operating conditions for reagent concentrations and temperature were established. Linear calibration curve was obtained in the range of 85.77 – 513.45ng mL-1 with standard deviation from 1.77 to 4.55 %-. The optimized conditions yielded a theoretical detection limit of 15.20 ng mL-1 based on 3.3So criterion. Commonly used excipients and other additives such as talc, glucose, fructose, lactose, starch, magnesium stearate, microcrystalline cellulose and several ions were found not to have interference.
Conclusion: The developed method is sensitive, accurate and reproducible and could be used for routine analysis of metronidazole in pharmaceutical preparations.
Keywords: Metronidazole, Kinetic spectrometry, Validation, Pharmaceutical preparation.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.